Thyroid cancer: assessment and management

You can now review and comment on this draft guideline.

The consultation closes at 5pm on Thursday 04^th August 2022

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline – just the recommendations

Evidence reviews

• Evidence review A - ultrasound accuracy and threshold of nodule size and classification
• Evidence review B- indications for blood tests
• Evidence review C - radioisotope scan
• Evidence review D - diagnostic accuracy of fine needle aspiration cytology
• Evidence review E - efficacy of repeat FNAC, active surveillance, or discharge
• Evidence review F - molecular testing
• Evidence review G - imaging for further staging
• Evidence review H - the clinical and cost effectiveness of initial treatments for people with differentiated thyroid cancer
• Evidence review I - thyrotropin alfa
• Evidence review J - RAI vs no RAI
• Evidence review K - activity of radioactive iodine after thyroidectomy
• Evidence review L - clinical and cost effectiveness of external beam radiotherapy, for people with residual, metastatic or recurrent thyroid cancer
• Evidence review M - TSH suppression vs no suppression
• Evidence review N - duration of TSH suppression
• Evidence review O - measurement of thyroglobulin
• Evidence review P - stimulated or highly sensitive thyroglobulin assays
• Evidence review Q - frequency and duration of follow up
• Evidence review R - the information, education and support needed by people with suspected and confirmed thyroid cancer, and their families and carers

Supplementary Documents

• Methods
• Acknowledgements
• Economic model report

If you want to review the economic model, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment 3
• Committee membership list
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: ThyroidCancer@nice.org.uk

Deadline: 5pm on Thursday 04^th August 2022

5. Economic model

The developer has produced an economic model to support the guideline on Thyroid cancer: assessment and management. To receive an executable version of this model, please submit a request to ThyroidCancer@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: 5pm on Thursday 04^th August 2022.